SMC4 and cervical cancer: Table 2 shows the overlap between the reference signature behavior from database 1 and the behavior of genes in database 2. The overlap amounts to 28 genes (29 probes with two probes for gene SMC4), which is 71.8% of the original signature, evidencing the effectiveness of the method. Table 2 also summarizes evidence found in the literature to support the genes' potential biomarking role in cervix cancer or in other types of cancer.